Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Constitutive Activity of the Human β1-Adrenergic Receptor in β1-Receptor Transgenic Mice

Stefan Engelhardt, Yvonne Grimmer, Guo-Huang Fan and Martin J. Lohse
Molecular Pharmacology October 2001, 60 (4) 712-717;
Stefan Engelhardt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yvonne Grimmer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guo-Huang Fan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin J. Lohse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We tested the hypothesis that the human β1-adrenergic receptor displays constitutive activity and that β-adrenergic antagonists differ in their ability to modulate this constitutive activity. Transfection of the cDNAs of the human β1- and β2-adrenergic receptors into COS-7 cells caused increases in basal cAMP that were proportional to the receptor levels, thus demonstrating constitutive activity for both subtypes. At comparable receptor levels, the increase in basal cAMP was about 5-fold higher for the β2- than for the β1-subtype. As a model for enhanced β-adrenergic signaling at the whole-organ level, we used transgenic mice with heart-specific overexpression of the human β1-adrenergic receptor. In this model, the β1-adrenergic receptor displayed constitutive activity as evidenced by a higher spontaneous beating rate of isolated right atria from β1-transgenic versus wild-type mice. This difference was abolished by the addition of CGP20712A, demonstrating inverse agonist properties of this compound. We then tested whether various β-adrenergic antagonists currently in clinical use for the treatment of heart failure differ in their ability to modulate constitutive activity of the cardiac β1-adrenergic receptor. The β1-selective antagonists metoprolol and bisoprolol showed significant inverse agonist activity at the β1-adrenergic receptor. Carvedilol behaved as a neutral antagonist and xamoterol displayed marked partial agonist activity. We conclude that the human β1-adrenergic receptor displays constitutive activity that is considerably lower than that of the β2-subtype. β-Adrenergic antagonists currently in clinical use differ in their ability to exert inverse agonist activity at the human β1-adrenergic receptor, which may contribute to their therapeutic effects.

Footnotes

  • These studies were supported by grants from the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Industrie, and the European Union.

  • Abbreviations:
    αMHC
    α myosin heavy chain
    HPLC
    high-performance liquid chromatography
    • Received February 5, 2001.
    • Accepted June 1, 2001.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 60 (4)
Molecular Pharmacology
Vol. 60, Issue 4
1 Oct 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Constitutive Activity of the Human β1-Adrenergic Receptor in β1-Receptor Transgenic Mice
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Constitutive Activity of the Human β1-Adrenergic Receptor in β1-Receptor Transgenic Mice

Stefan Engelhardt, Yvonne Grimmer, Guo-Huang Fan and Martin J. Lohse
Molecular Pharmacology October 1, 2001, 60 (4) 712-717;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Constitutive Activity of the Human β1-Adrenergic Receptor in β1-Receptor Transgenic Mice

Stefan Engelhardt, Yvonne Grimmer, Guo-Huang Fan and Martin J. Lohse
Molecular Pharmacology October 1, 2001, 60 (4) 712-717;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
  • Mechanism of Selective Action of Paraherquamide A
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics